Pharmafile Logo
Pharmafocus logo
Advanced Search

Alcon

Showing 13 posts of 13 posts found.

d2644e613f

Novartis eyecare unit Alcon to set up new HQ in Geneva, Switzerland

September 11, 2018
Manufacturing and Production Alcon, Novartis, eye care, pharma

Alcon, the eyecare unit of Novartis, is set to move to a new home next year, after its parent company …

News

Novartis spins off Alcon as CEO focuses drug search

June 29, 2018
Medical Communications, Sales and Marketing Alcon, Novartis, eye care, pharma

Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company.Novartis has …

News
novartissunlight_copy

Novartis misses Q3 forecast with $390m settlement payment, strong dollar

October 27, 2015
Manufacturing and Production, Sales and Marketing Alcon, Novartis, Sandoz

Novartis reported lower-than anticipated third quarter earnings on Tuesday, hit by the $390 million settlement it has agreed to pay …

News
Novartis

Sandoz and pharma division boost Novartis sales

July 21, 2015
Sales and Marketing Alcon, Novartis, Sandoz, financial performance, financial results, income, profits, sales

Sales at Novartis reached $12.7 billion in the second quarter of 2015, while its operating income was $2.3 billion, the …

News
Lens image

Novartis forms alliance with Google on ‘smart lens’

July 15, 2014
Medical Communications, Sales and Marketing Alcon, Novartis, diabetes, e-health, google, smart lens, wearable

Novartis eye care division Alcon has struck a deal with Google to develop a ‘smart’ contact lens designed to help …

News
jeff_george_sandoz

Novartis appoints new heads at Alcon, Sandoz

April 9, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alcon, Novartis, Sandoz

Appointment
china_flag

Novartis launches China investigation

September 18, 2013
Medical Communications, Sales and Marketing Alcon, China, Novartis, corrpution

News
nice_sign

ThromboGenics/Novartis’ Jetrea gains NICE ‘yes’

August 30, 2013
Alcon, Jetrea, NICE, Novartis, ThromboGenics

News

Novartis becomes global eye health leader as Alcon deal finalised

December 15, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Alcon, Lucentis, Novartis, eye care, eye health, ophthalmology

Novartis’ 11-month standoff with Alcon shareholders has ended, allowing it to acquire all the remaining shares in the ophthalmology firm. …

News

Two $1 billion dollar acquisition deals go through

August 11, 2010
Sales and Marketing Alcon, M&A, MA, Novartis, Ratiopharm, Teva

Two major acquisition deals mounted by Teva and Novartis are in their final stages as they move to complete potentially …

News

Novartis shines in first quarter

April 21, 2010
Sales and Marketing 2010 financials, Alcon, Novartis

Novartis has had a very strong first quarter, its first under new chief executive Joe Jimenez, delivering a 25% increase …

News

Alcon directors protest Novartis takeover bid

January 6, 2010
Research and Development, Sales and Marketing Alcon, Novartis

An independent committee of directors of Alcon has expressed its disappointment with the recent takeover bid from Novartis, saying the …

News

Novartis to acquire majority stake in Alcon

January 5, 2010
Sales and Marketing Alcon, Novartis, eye care

Novartis plans to gain a majority hold of global eye care leader Alcon, significantly boosting its presence in the sector. …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023